Investment Objective: |
The fund tracks the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The Index is designed to provide exposure to equity securities of exchange-listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The Index constituents are determined by an Index committee that looks at companies focusing on the application of genetic technologies to prevent and treat disease the applications of human genetic technologies to new classes of consumer products personalized for each individual the transformation of agriculture, aquaculture, and food production, creating healthier and more sustainable models for feeding the growing global population biological re-engineering used to produce an increasing percentage of the physical inputs needed for manufacturing and/or DNA as a storage solution (collectively, BioRevolution Activities). |